Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zimmer Biomet Holdings ( (ZBH) ) has issued an update.
On May 12, 2026, Zimmer Biomet announced it now expects to repurchase up to $1 billion of its common stock during fiscal 2026, raising its planned buybacks by $250 million compared with prior capital allocation assumptions. All purchases will be executed under an existing $1.5 billion authorization approved in February 2026, with shares potentially repurchased in the open market or via structured agreements, signaling a stepped-up return of capital that may support earnings per share and shareholder value.
The timing and scale of the buybacks will depend on factors including market conditions, the stock price, available capital and alternative uses of cash, giving management flexibility in execution. The move underscores Zimmer Biomet’s confidence in its financial position and cash generation, and could bolster its standing with investors amid ongoing competition and macroeconomic uncertainties in the medical technology sector.
The most recent analyst rating on (ZBH) stock is a Hold with a $100.00 price target. To see the full list of analyst forecasts on Zimmer Biomet Holdings stock, see the ZBH Stock Forecast page.
Spark’s Take on ZBH Stock
According to Spark, TipRanks’ AI Analyst, ZBH is a Neutral.
The score is supported most by a solid underlying financial base (strong gross/EBITDA margins and moderate leverage) and a constructive earnings update with raised EPS and free-cash-flow guidance. The main offset is weak technical positioning (price below key moving averages with bearish momentum signals), while valuation support is limited by the lack of a usable P/E and only a modest dividend yield.
To see Spark’s full report on ZBH stock, click here.
More about Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a global medical technology leader focused on maximizing mobility and improving health through a broad portfolio of orthopedic and related solutions. The company offers innovative products and integrated digital and robotic technologies that leverage data analytics and artificial intelligence, and operates in more than 25 countries with sales in over 100 markets worldwide.
Average Trading Volume: 2,248,588
Technical Sentiment Signal: Sell
Current Market Cap: $15.93B
See more insights into ZBH stock on TipRanks’ Stock Analysis page.